Trial Profile
A phase I study of three modified-release oral formulations of omecamtiv mecarbil in healthy volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Jun 2008
Price :
$35
*
At a glance
- Drugs Omecamtiv mecarbil (Primary)
- Indications Heart failure
- Focus Pharmacokinetics
- Sponsors Cytokinetics
- 18 Jun 2008 New trial record.